These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32240338)

  • 1. [Survival advantage for resection of primary gastrointestinal neuroendocrine tumors with hepatic metastases].
    Weber F; Dralle H
    Chirurg; 2020 Jun; 91(6):512. PubMed ID: 32240338
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of liver metastases from gastrointestinal endocrine tumors.
    Boleslawski E; Dharancy S; Truant S; Pruvot FR
    Gastroenterol Clin Biol; 2010; 34(4-5):274-82. PubMed ID: 20347242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Labgaa I; Slankamenac K; Schadde E; Jibara G; Alshebeeb K; Mentha G; Clavien PA; Schwartz M
    Am J Surg; 2018 Jan; 215(1):125-130. PubMed ID: 29061283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors.
    Que FG; Sarmiento JM; Nagorney DM
    Cancer Control; 2002; 9(1):67-79. PubMed ID: 11907468
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases.
    Croome KP; Burns JM; G Que F; Nagorney DM
    Ann Surg Oncol; 2016 Oct; 23(11):3693-3698. PubMed ID: 27188296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery.
    Jaeck D; Oussoultzoglou E; Bachellier P; Lemarque P; Weber JC; Nakano H; Wolf P
    World J Surg; 2001 Jun; 25(6):689-92. PubMed ID: 11376398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The surgical management of neuroendocrine tumour hepatic metastases.
    Pathak S; Dash I; Taylor MR; Poston GJ
    Eur J Surg Oncol; 2013 Mar; 39(3):224-8. PubMed ID: 23290582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Infectious Complications After Simultaneous Gastrointestinal and Liver Resections for Neuroendocrine Tumor Metastases.
    Acosta LF; Chacon E; Eman P; Dugan A; Davenport D; Gedaly R
    J Surg Res; 2019 Mar; 235():244-249. PubMed ID: 30691802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
    Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
    Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staged hepatectomy and whipple procedure in metastatic gastroenteropancreatic endocrine carcinoma: report of a case.
    Marchesi F; Sarli L; Violi V; Roncoroni L
    Int Surg; 2006; 91(5):247-50. PubMed ID: 17061667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Neuroendocrine Liver Metastases.
    Farley HA; Pommier RF
    Surg Oncol Clin N Am; 2016 Jan; 25(1):217-25. PubMed ID: 26610783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection for primary hepatic neuroendocrine tumours: report of three cases and review of the literature.
    Donadon M; Torzilli G; Palmisano A; Del Fabbro D; Panizzo V; Maggioni M; Santambrogio R; Montorsi M
    Eur J Surg Oncol; 2006 Apr; 32(3):325-8. PubMed ID: 16426802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
    Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
    J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach.
    Saxena A; Chua TC; Sarkar A; Chu F; Liauw W; Zhao J; Morris DL
    Surgery; 2011 Feb; 149(2):209-20. PubMed ID: 20674950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic neuroendocrine metastases: does intervention alter outcomes?
    Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
    J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.
    Yedibela S; Gohl J; Graz V; Pfaffenberger MK; Merkel S; Hohenberger W; Meyer T
    Ann Surg Oncol; 2005 Oct; 12(10):778-85. PubMed ID: 16132374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation for Neuroendocrine Tumors: What Have We Learned?
    Lim C; Lahat E; Osseis M; Sotirov D; Salloum C; Azoulay D
    Semin Liver Dis; 2018 Nov; 38(4):351-356. PubMed ID: 30357772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
    Zhang XF; Beal EW; Chakedis J; Lv Y; Bagante F; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Weiss M; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1821-1830. PubMed ID: 28730354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hepatic neuroendocrine tumor: Five cases with different preoperative diagnoses.
    Yalav O; Ülkü A; Akçam TA; Demiryürek H; Doran F
    Turk J Gastroenterol; 2012 Jun; 23(3):272-8. PubMed ID: 22798119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.